高级检索
    盛桂凤, 毕延智, 董益忠, 张亚平, 宋红蕾, 徐建忠. 葡萄糖酸钙防治改良FOLFOX4方案治疗晚期胃肠肿瘤神经毒性观察[J]. 蚌埠医科大学学报, 2009, 34(12): 1106-1108.
    引用本文: 盛桂凤, 毕延智, 董益忠, 张亚平, 宋红蕾, 徐建忠. 葡萄糖酸钙防治改良FOLFOX4方案治疗晚期胃肠肿瘤神经毒性观察[J]. 蚌埠医科大学学报, 2009, 34(12): 1106-1108.
    shu
    SHENG Gui-feng, BI Yan-zhi, DONG Yi-zhong, ZHANG Ya-ping, SONG Hong-lei, XU Jian-zhong. Calcium gluconate combined with modified FOLFOX4 regimen for treatment of advanced gastric and colorectal carcinoma[J]. Journal of Bengbu Medical University, 2009, 34(12): 1106-1108.
    Citation: SHENG Gui-feng, BI Yan-zhi, DONG Yi-zhong, ZHANG Ya-ping, SONG Hong-lei, XU Jian-zhong. Calcium gluconate combined with modified FOLFOX4 regimen for treatment of advanced gastric and colorectal carcinoma[J]. Journal of Bengbu Medical University, 2009, 34(12): 1106-1108.
    shu

    葡萄糖酸钙防治改良FOLFOX4方案治疗晚期胃肠肿瘤神经毒性观察

    Calcium gluconate combined with modified FOLFOX4 regimen for treatment of advanced gastric and colorectal carcinoma

      摘要
    • 摘要: 目的:观察葡萄糖酸钙防治改良FOLFOX4方案治疗晚期胃肠肿瘤神经毒性。方法:将196例胃肠肿瘤患者随机分为A、B两组,A组85例予以葡萄糖酸钙+改良FOLFOX4方案,在用草酸铂前、后缓慢推注5%葡萄糖溶液20ml+10%葡萄糖酸钙10ml各1次,每2周重复。B组111例采用改良FOLFOX4方案。结果:A组总有效率为45.88%,B组总有效率为46.85%,两组差异无统计学意义(P>0.05);A组神经毒性发生率为49.41%,B组为65.77%,两组差异有统计学意义(P<0.05)。结论:葡萄糖酸钙防治草酸铂神经毒性疗效好,且不影响含草酸铂的改良FOLFOX4方案临床疗效。

       

      Abstract: Objective: To assess the neuroprotectant effect of Calcium gluconate combined with modified FOLFOX4 regimen on oxaliplatin-induced neurotoxicity.Methods: One hundred and ninety-six patients were randomly divided into two groups.Group A were administered modified FOLFOX4 regimen and Calcium gluconate.They were administered infusion of 5% Calcium gluconate(1 g) before and after oxaliplatin,and the regimen was repeated every two weeks.Group B received modified FOLFOX4 regimen only.Results: The response rate was 45.88%(39/85) and 46.85%(52/111) in group A and group B respectively(P>0.05),and the incidence of neurotoxicity was 49.41% and 65.77% in group A and group B respectively(P<0.05).Conclusions: Infusion of Calcium gluconate can effectively reduce the incidence of oxaliplatin-induced neurotoxicity without interfering the effect of modified FOLFOX4 regimen.

       

      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回